Article metrics
Other content recommended for you
- Justified deception? The single blind placebo in drug research
- Vonoprazan prevents ulcer recurrence during long-term NSAID therapy: randomised, lansoprazole-controlled non-inferiority and single-blind extension study
- Multinational, double-blind, randomised, placebo-controlled, prospective study of esomeprazole in the prevention of recurrent peptic ulcer in low-dose acetylsalicylic acid users: the LAVENDER* study
- Drug treatments in upper gastrointestinal bleeding: value of endoscopic findings as surrogate end points
- Vonoprazan prevents low-dose aspirin-associated ulcer recurrence: randomised phase 3 study
- Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review
- Prevention of peptic ulcers with esomeprazole in patients at risk of ulcer development treated with low-dose acetylsalicylic acid: a randomised, controlled trial (OBERON)
- The placebo effect and its determinants in osteoarthritis: meta-analysis of randomised controlled trials
- Meta-analysis of short term low dose prednisolone versus placebo and non-steroidal anti-inflammatory drugs in rheumatoid arthritis
- Oral montelukast in acute asthma exacerbations: a randomised, double-blind, placebo-controlled trial